These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 21289112)

  • 1. Influence of Gag-protease-mediated replication capacity on disease progression in individuals recently infected with HIV-1 subtype C.
    Wright JK; Novitsky V; Brockman MA; Brumme ZL; Brumme CJ; Carlson JM; Heckerman D; Wang B; Losina E; Leshwedi M; van der Stok M; Maphumulo L; Mkhwanazi N; Chonco F; Goulder PJ; Essex M; Walker BD; Ndung'u T
    J Virol; 2011 Apr; 85(8):3996-4006. PubMed ID: 21289112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pol-Driven Replicative Capacity Impacts Disease Progression in HIV-1 Subtype C Infection.
    Ojwach DBA; MacMillan D; Reddy T; Novitsky V; Brumme ZL; Brockman MA; Ndung'u T; Mann JK
    J Virol; 2018 Oct; 92(19):. PubMed ID: 29997209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gag-protease-mediated replication capacity in HIV-1 subtype C chronic infection: associations with HLA type and clinical parameters.
    Wright JK; Brumme ZL; Carlson JM; Heckerman D; Kadie CM; Brumme CJ; Wang B; Losina E; Miura T; Chonco F; van der Stok M; Mncube Z; Bishop K; Goulder PJ; Walker BD; Brockman MA; Ndung'u T
    J Virol; 2010 Oct; 84(20):10820-31. PubMed ID: 20702636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of a significant impact of Gag-Protease-mediated HIV-1 replication capacity on clinical parameters in treatment-naive Japanese individuals.
    Sakai K; Chikata T; Brumme ZL; Brumme CJ; Gatanaga H; Oka S; Takiguchi M
    Retrovirology; 2015 Nov; 12():98. PubMed ID: 26585907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Consequences of HLA-B*13-Associated Escape Mutations on HIV-1 Replication and Nef Function.
    Shahid A; Olvera A; Anmole G; Kuang XT; Cotton LA; Plana M; Brander C; Brockman MA; Brumme ZL
    J Virol; 2015 Nov; 89(22):11557-71. PubMed ID: 26355081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early selection in Gag by protective HLA alleles contributes to reduced HIV-1 replication capacity that may be largely compensated for in chronic infection.
    Brockman MA; Brumme ZL; Brumme CJ; Miura T; Sela J; Rosato PC; Kadie CM; Carlson JM; Markle TJ; Streeck H; Kelleher AD; Markowitz M; Jessen H; Rosenberg E; Altfeld M; Harrigan PR; Heckerman D; Walker BD; Allen TM
    J Virol; 2010 Nov; 84(22):11937-49. PubMed ID: 20810731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of HLA-B*81-associated mutations in HIV-1 Gag on viral replication capacity.
    Wright JK; Naidoo VL; Brumme ZL; Prince JL; Claiborne DT; Goulder PJ; Brockman MA; Hunter E; Ndung'u T
    J Virol; 2012 Mar; 86(6):3193-9. PubMed ID: 22238317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mother-to-Child HIV Transmission Bottleneck Selects for Consensus Virus with Lower Gag-Protease-Driven Replication Capacity.
    Naidoo VL; Mann JK; Noble C; Adland E; Carlson JM; Thomas J; Brumme CJ; Thobakgale-Tshabalala CF; Brumme ZL; Brockman MA; Goulder PJR; Ndung'u T
    J Virol; 2017 Sep; 91(17):. PubMed ID: 28637761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subtype-Specific Differences in Gag-Protease-Driven Replication Capacity Are Consistent with Intersubtype Differences in HIV-1 Disease Progression.
    Kiguoya MW; Mann JK; Chopera D; Gounder K; Lee GQ; Hunt PW; Martin JN; Ball TB; Kimani J; Brumme ZL; Brockman MA; Ndung'u T
    J Virol; 2017 Jul; 91(13):. PubMed ID: 28424286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of HLA-B*52:01-Driven Escape Mutations on Viral Replicative Capacity.
    Tsai MC; Singh S; Adland E; Goulder P
    J Virol; 2020 Jun; 94(13):. PubMed ID: 32321820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subtype-specific differences in Gag-protease replication capacity of HIV-1 isolates from East and West Africa.
    Farinre O; Gounder K; Reddy T; Tongo M; Hare J; Chaplin B; Gilmour J; Kanki P; Mann JK; Ndung'u T
    Retrovirology; 2021 May; 18(1):11. PubMed ID: 33952315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human leukocyte antigen-specific polymorphisms in HIV-1 Gag and their association with viral load in chronic untreated infection.
    Brumme ZL; Tao I; Szeto S; Brumme CJ; Carlson JM; Chan D; Kadie C; Frahm N; Brander C; Walker B; Heckerman D; Harrigan PR
    AIDS; 2008 Jul; 22(11):1277-86. PubMed ID: 18580606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impaired replication capacity of acute/early viruses in persons who become HIV controllers.
    Miura T; Brumme ZL; Brockman MA; Rosato P; Sela J; Brumme CJ; Pereyra F; Kaufmann DE; Trocha A; Block BL; Daar ES; Connick E; Jessen H; Kelleher AD; Rosenberg E; Markowitz M; Schafer K; Vaida F; Iwamoto A; Little S; Walker BD
    J Virol; 2010 Aug; 84(15):7581-91. PubMed ID: 20504921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A restriction enzyme based cloning method to assess the in vitro replication capacity of HIV-1 subtype C Gag-MJ4 chimeric viruses.
    Claiborne DT; Prince JL; Hunter E
    J Vis Exp; 2014 Aug; (90):. PubMed ID: 25225725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significant reductions in Gag-protease-mediated HIV-1 replication capacity during the course of the epidemic in Japan.
    Nomura S; Hosoya N; Brumme ZL; Brockman MA; Kikuchi T; Koga M; Nakamura H; Koibuchi T; Fujii T; Carlson JM; Heckerman D; Kawana-Tachikawa A; Iwamoto A; Miura T
    J Virol; 2013 Feb; 87(3):1465-76. PubMed ID: 23152532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid HIV disease progression following superinfection in an HLA-B*27:05/B*57:01-positive transmission recipient.
    Brener J; Gall A; Hurst J; Batorsky R; Lavandier N; Chen F; Edwards A; Bolton C; Dsouza R; Allen T; Pybus OG; Kellam P; Matthews PC; Goulder PJR
    Retrovirology; 2018 Jan; 15(1):7. PubMed ID: 29338738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of Mutations on Replicative Fitness and Major Histocompatibility Complex Class I Binding Affinity Are Among the Determinants Underlying Cytotoxic-T-Lymphocyte Escape of HIV-1 Gag Epitopes.
    Du Y; Zhang TH; Dai L; Zheng X; Gorin AM; Oishi J; Wu TT; Yoshizawa JM; Li X; Yang OO; Martinez-Maza O; Detels R; Sun R
    mBio; 2017 Nov; 8(6):. PubMed ID: 29184023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preferential CTL targeting of Gag is associated with relative viral control in long-term surviving HIV-1 infected former plasma donors from China.
    Jia M; Hong K; Chen J; Ruan Y; Wang Z; Su B; Ren G; Zhang X; Liu Z; Zhao Q; Li D; Peng H; Altfeld M; Walker BD; Yu XG; Shao Y
    Cell Res; 2012 May; 22(5):903-14. PubMed ID: 22290423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of HLA selection pressure on HIV fitness at a population level in Mexico and Barbados.
    Juarez-Molina CI; Payne R; Soto-Nava M; Avila-Rios S; Valenzuela-Ponce H; Adland E; Leitman E; Brener J; Muenchhoff M; Branch S; Landis C; Reyes-Teran G; Goulder P
    J Virol; 2014 Sep; 88(18):10392-8. PubMed ID: 25008926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of transmitted Gag CTL polymorphisms in defining replicative capacity and early HIV-1 pathogenesis.
    Prince JL; Claiborne DT; Carlson JM; Schaefer M; Yu T; Lahki S; Prentice HA; Yue L; Vishwanathan SA; Kilembe W; Goepfert P; Price MA; Gilmour J; Mulenga J; Farmer P; Derdeyn CA; Tang J; Heckerman D; Kaslow RA; Allen SA; Hunter E
    PLoS Pathog; 2012; 8(11):e1003041. PubMed ID: 23209412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.